Apheresis Equipment Market share to exceed $4.5 bn by 2024 - PowerPoint PPT Presentation

About This Presentation
Title:

Apheresis Equipment Market share to exceed $4.5 bn by 2024

Description:

Get more details @ Global apheresis equipment market share was dominated by large corporations such as Terumo, Fresenius Kabi, Haemonetics and B.Braun Melsungen. The industry is oligopolistic in nature, marked by significant number of mergers and acquisitions and strategic collaborations. – PowerPoint PPT presentation

Number of Views:37

less

Transcript and Presenter's Notes

Title: Apheresis Equipment Market share to exceed $4.5 bn by 2024


1
Apheresis Equipment Market to witness growth of
11.4 from 2016 to 2024 Global Market Insights
Inc.
Fuel Cell Market size worth 25.5bn by 2024
2
Key Insights from Apheresis Equipment Market
  • Global Market Insights, Inc. says, Apheresis
    Equipment Industry, which was valued at USD 1.7
    billion in 2015, is forecast to hit USD 4.5
    billion by 2024.
  • Beneficial medical compensation plans for
    apheresis procedures will be one of the key
    factors accelerating apheresis equipment market
    growth.
  • Industry experts are heavily involved in
    strategic mergers acquisitions and novel
    product launches to sustain the competition. Just
    recently, Terumo, a world leader specializing in
    cellular and apheresis technology, announced the
    launch of an innovative apheresis device to treat
    Myasthenia Gravis (MG) disease and Guillain-Barré
    syndrome.
  • High incidences of blood-related disorders such
    as leukemia and sickle cell anemia coupled with
    the bulging need for innovative blood component
    separation techniques will chalk out a profitable
    roadmap for apheresis equipment industry.
  • Apheresis equipment is extensively used in the
    treatment of neurology, renal diseases, and
    hematology.

3
Continued...
  • Based on the product trends, apheresis equipment
    market is classified into disposable apheresis
    kits and apheresis machines.
  • Growing popularity along with significantly lower
    costs will drive the product demand, leading to
    disposable apheresis equipment market earning a
    revenue of USD 2,944 million by 2024.
  • Europe apheresis equipment market was worth USD
    365 million in 2015 and will collect a revenue of
    more than USD 1,084 million by 2024, owing to the
    implementation of supportive rules and
    regulations.
  • U.S. apheresis equipment industry contributed
    majorly toward the North America market size by
    exceeding a share of 87 in 2015 and will exhibit
    an annual growth rate of more than 9 over the
    period of 2016 to 2024.
  • Notable participants in apheresis equipment
    market are Fresenius Kabi, B.Braun Melsungen,
    Terumo Corporation, Haemonetics, Kawasumi
    Laboratories, Therakos, Fenwal Inc, and Hemacare
    Corporation.

4
U.S. Apheresis Equipment Market Size, by
procedure, 2012- 2024 (USD Million)

5

Browse Full Market Research Report On Apheresis
Equipment Market _at_ http//bit.ly/2gXwLhN
Request for a Sample of this Research Report
_at_ https//www.gminsights.com/request-sample/detail
/847 https//www.gminsights.com/request-sample/de
tail/49
6
Table of Content
Chapter 1. Methodology and Scope 1.1. Research
Methodology 1.1.1. Initial data
exploration 1.1.2. Statistical modeling and
forecast 1.1.3. Industry insights and
validation 1.1.4. Research parameters 1.2.
Data Sources 1.2.1. Primary 1.2.2.
Secondary Chapter 2. Executive Summary 2.1.
Apheresis Equipment Market 3600 synopsis, 2012 -
2024 2.1.1. Business trends 2.1.2. Regional
trends 2.1.3. Product trends
7
Table of Content
Chapter 3. Apheresis Equipment Industry
Insights 3.1. Industry segmentation 3.2.
Industry size and forecast, 2012 - 2024 3.3.
Industry impact forces 3.3.1. Growth
drivers 3.3.1.1. Growing demand for platelets
and plasma 3.3.1.2. Increasing prevalence of
target diseases 3.3.1.3. Presence of favorable
reimbursement policies 3.3.1.4. Implementation
of supportive government initiatives 3.3.2.
Market restraints 3.3.2.1. Risks associated
with apheresis 3.3.2.2. Lack of donor
availability histocompatibility 3.4. Growth
potential analysis 3.5. Regulatory
Landscape 3.5.1. U.S. 3.5.2. Europe 3.5.3.
China
8
Table of Content
3.6. Porters analysis 3.7. PESTEL
analysis 3.8. Company market share analysis,
2015
9
Stay In Touch Website www.gminsights.com Soci
al Media
Write a Comment
User Comments (0)
About PowerShow.com